We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
DYMISTA/ DYLASTINE (Viatris Pty Ltd)
Product name
DYMISTA/ DYLASTINE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
167 (255 working days)
Active ingredients
azelastine hydrochloride, fluticasone propionate
Registration type
EOI
Indication
Symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 6 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.